PRVA Privia Health Group Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 91
Relative Strength: Rel. Strength: 31
Relative Valuation: Rel. Valuation: 47
Relative Profitability: Rel. Profitability: 31

EPS in 2026 (TTM): $0.23

Last Report Period Date: Jun 30, 2026

As of August 2026, PRVA's trailing twelve months (TTM) EPS stands at $0.23, according to the latest financial reports. In 2025, the company recorded an earnings per share (EPS) of $0.19, which represents an increase compared to its EPS of $0.12 in 2024. PRVA reported an EPS of $0.07 for the quarterly report ending on Jun 30, 2026.

PRVA earnings history

Historical annual and quarterly earnings per share (EPS) data for Privia Health Group
EPS (TTM)
$0.23
EPS Growth YoY (Quarterly)
250%
EPS (Quarterly)
$0.07
EPS Growth (Quarterly)
250%

For 2025, Privia Health Group's EPS was $0.19, an increase of 58.3% from $0.12 in 2024. For the quarter ending Jun 30, 2026, the EPS was $0.07, showing a 250% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of June 2026 is $0.23. In 2024, the annual EPS was $0.12, showing a decrease of 40% from 2023.

PRVA EPS vs price chart

PRVA EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
250%
EPS growth YoY
58.3%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
-10.5%

Privia Health Group has recorded an increase in EPS of 250% over the last 12 months (YoY, quarterly). Privia Health Group had an average annual EPS growth rate of -10.5% over the last 5 years.

PRVA Earnings Waterfall

Breakdown of revenue, profit and net income for Privia Health Group

All data is based on quarterly TTM periods, unless otherwise specified.